All News

I confronted my oncologist and dentist about the research I found. After doing their own research, they told me that cancer and treatment can weaken bone structure including teeth. I wish I had been told this earlier.

The Food and Drug Administration noted the trial design was acceptable for researchers to evaluate VERU-111 in in metastatic castration and novel androgen-blocking agent resistant prostate cancer.

The FDA has approved a generic form of the intravenous chemotherapy pemetrexed for use by itself in patients with locally advanced or metastatic non-squamous non-small cell lung cancer that has not progressed following four cycles of initial platinum-based chemotherapy.

The agent, in combination with the current standard of care, is being evaluated as a frontline treatment for patients with high-risk Denovo Genomic Marker 1 (DGM1)–positive DLBCL.

How one cancer thriver has found a small corner of control in an uncontrollable place.

“Through patients’ eyes, augmented intelligence may improve health care quality but should be implemented in a manner that preserves the integrity of the human physician-patient relationship,” the authors wrote.

At a median follow-up of 10 months, all patients who received Tafinlar plus Mekinist achieved an overall response rate of 51%.

On social media, CURE® recently asked its readers to share some tips for others for coping with roadblocks they might experience on their cancer journey. Here, we share some of their responses.

If you encounter mistreatment by any of your cancer providers, do not be afraid to expose them. If they are hurting you, they could be hurting others.

Dr. Jennifer L. Atlas notes that while these results could lead to a paradigm shift, surgery and radiation aren’t being eliminated as treatment options.

Life can be ridiculous, one survivor writes.

While it may seem beneficial to attach ourselves to the memories of our pre-cancer existence, it does little to help us focus on the here and now.

Anxiety, fear and panic may be some of the most difficult feelings to manage during cancer treatment. Here are some ways of dealing with these emotions to make you feel better.

Could paradigm shifts in cancer research help find a cure for cholangiocarcinoma? Experts discuss.

After lifesaving medicine became available to treat hepatitis C virus, a risk factor for liver cancer, racial inequities in the death rate from the malignancy began a steady upward climb.

For a long time, I refused to acknowledge the lingering effects of neuropathy. I found a way to joke about it and told everybody I was clumsy. To acknowledge the elephant in the room, I had to admit I needed to explore balance further.

From the bi-partisan Research to Accelerate Cures and Equity (RACE) for Children Act implementing an FDA mandate that all new cancer therapies for adults must also be studied in children, to the “Iron Man” of baseball Cal Ripken Jr. announcing he’s cancer free after a February diagnosis, here’s what’s happening in the cancer landscape this week.

Specific measures of a tumor’s texture and intensity as they appear on CT images can help determine how much treatment patients with early stage lung cancer need, a study found.

The Food and Drug Administration (FDA) has approved the expansion of Kyprolis (carfilzomib) in combination to with Darzalex (daratumumab) plus dexamethasone in once- and twice-weekly dosing regimens for the treatment of patients with relapsed or refractory multiple myeloma who have received a maximum of three prior lines of therapy.

Circulating tumor DNA and circulating tumor cells are usual markers for minimal residual disease in patients with triple negative breast cancer, but new research shows they are also valuable indicators of disease recurrence.

What had eluded my wife and I, and not without great consequence, was the damage cancer had inflicted upon our apartment. Years and years of trauma, PTSD triggers, and bone-chilling memories had snuck in and festered around us like cockroaches.

This quick weeknight dinner option from the oncology dietitians at the John Theurer Cancer Center is high in protein and fiber, yet low in carbs, and is sure to be a crowd pleaser.

In addition to not delaying disease worsening, the immunotherapy Tecentriq was associated with a negative survival trend, but data on the length of life were immature at the time of analysis and further analysis is planned.

“With data showing a two-fold increase in disease-free survival with the vaccine alone and in combination with checkpoint inhibitors, we hope to one day change the narrative for people with melanoma — turning this disease into a chronic condition that can be treated and managed over time,” said Dr. Mark B. Faries.

“This study has highlighted the potential benefit of supportive resources to help women with (metastatic breast cancer) guard against potentially severe cancer-related financial losses for themselves and others within their households,” the authors wrote.

If approved by the FDA, Imfinzi could be administered every four weeks at a fixed dose in patients with stage 3 NSCLC after they received chemoradiation, as well as in patients with previously treated bladder cancer.

While 75% of patients with gynecological cancers and COVID-19 will recover, new data from New York City shows specific risks for patients with cancer infected with COVID-19.

The Food and Drug Administration granted a priority review to the new drug application for trilaciclib for patients with small cell lung cancer.

New research has found that the risk for invasive prostate cancer increases significantly when patients have a family history of PBSIN along with invasive prostate cancer.

Precious time, which we cancer survivors know is fleeting, is flying by and we all feel robbed.